DK1517679T3 - Ortosubstituerede benzoesyrederivater til behandling af insulinresistens - Google Patents
Ortosubstituerede benzoesyrederivater til behandling af insulinresistensInfo
- Publication number
- DK1517679T3 DK1517679T3 DK03732714T DK03732714T DK1517679T3 DK 1517679 T3 DK1517679 T3 DK 1517679T3 DK 03732714 T DK03732714 T DK 03732714T DK 03732714 T DK03732714 T DK 03732714T DK 1517679 T3 DK1517679 T3 DK 1517679T3
- Authority
- DK
- Denmark
- Prior art keywords
- ortho
- treatment
- benzoic acid
- acid derivatives
- insulin resistance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201936A SE0201936D0 (sv) | 2002-06-20 | 2002-06-20 | Therapeutic agents |
| PCT/GB2003/002591 WO2004000294A1 (en) | 2002-06-20 | 2003-06-17 | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1517679T3 true DK1517679T3 (da) | 2008-05-19 |
Family
ID=20288294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03732714T DK1517679T3 (da) | 2002-06-20 | 2003-06-17 | Ortosubstituerede benzoesyrederivater til behandling af insulinresistens |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1517679B1 (sv) |
| JP (1) | JP2005535618A (sv) |
| KR (1) | KR20050014015A (sv) |
| CN (1) | CN1307988C (sv) |
| AR (1) | AR039714A1 (sv) |
| AT (1) | ATE385790T1 (sv) |
| AU (1) | AU2003240100B2 (sv) |
| BR (1) | BR0311839A (sv) |
| CA (1) | CA2490684A1 (sv) |
| DE (1) | DE60319082T2 (sv) |
| DK (1) | DK1517679T3 (sv) |
| ES (1) | ES2299703T3 (sv) |
| HK (1) | HK1074779A1 (sv) |
| IL (1) | IL165670A0 (sv) |
| IS (1) | IS7626A (sv) |
| MX (1) | MXPA04012685A (sv) |
| NO (1) | NO20045223L (sv) |
| NZ (1) | NZ536971A (sv) |
| PL (1) | PL375080A1 (sv) |
| PT (1) | PT1517679E (sv) |
| RU (1) | RU2288912C2 (sv) |
| SE (1) | SE0201936D0 (sv) |
| TW (1) | TW200407114A (sv) |
| UA (1) | UA76627C2 (sv) |
| WO (1) | WO2004000294A1 (sv) |
| ZA (1) | ZA200409693B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| EP1517883B8 (en) | 2002-06-20 | 2008-05-21 | AstraZeneca AB | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| PL219045B1 (pl) * | 2010-10-16 | 2015-03-31 | Inst Chemii Organicznej Polskiej Akademii Nauk | Nowe estry (acyloksymetylo)akrylamidu, kompozycja farmaceutyczna zawierająca je oraz ich zastosowanie |
| US10653681B2 (en) | 2016-03-16 | 2020-05-19 | Recurium Ip Holdings, Llc | Analgesic compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| JP4618845B2 (ja) * | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体 |
| US6509374B2 (en) * | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
-
2002
- 2002-06-20 SE SE0201936A patent/SE0201936D0/sv unknown
-
2003
- 2003-06-17 WO PCT/GB2003/002591 patent/WO2004000294A1/en active IP Right Grant
- 2003-06-17 AT AT03732714T patent/ATE385790T1/de not_active IP Right Cessation
- 2003-06-17 EP EP03732714A patent/EP1517679B1/en not_active Expired - Lifetime
- 2003-06-17 CA CA002490684A patent/CA2490684A1/en not_active Abandoned
- 2003-06-17 DK DK03732714T patent/DK1517679T3/da active
- 2003-06-17 AU AU2003240100A patent/AU2003240100B2/en not_active Ceased
- 2003-06-17 DE DE60319082T patent/DE60319082T2/de not_active Expired - Lifetime
- 2003-06-17 NZ NZ536971A patent/NZ536971A/en unknown
- 2003-06-17 RU RU2004135543/04A patent/RU2288912C2/ru not_active IP Right Cessation
- 2003-06-17 KR KR10-2004-7020689A patent/KR20050014015A/ko not_active Application Discontinuation
- 2003-06-17 PT PT03732714T patent/PT1517679E/pt unknown
- 2003-06-17 PL PL03375080A patent/PL375080A1/xx not_active Application Discontinuation
- 2003-06-17 BR BR0311839-8A patent/BR0311839A/pt not_active IP Right Cessation
- 2003-06-17 CN CNB038198533A patent/CN1307988C/zh not_active Expired - Fee Related
- 2003-06-17 MX MXPA04012685A patent/MXPA04012685A/es active IP Right Grant
- 2003-06-17 ES ES03732714T patent/ES2299703T3/es not_active Expired - Lifetime
- 2003-06-17 UA UA20041210012A patent/UA76627C2/uk unknown
- 2003-06-17 JP JP2004515008A patent/JP2005535618A/ja active Pending
- 2003-06-17 TW TW092116410A patent/TW200407114A/zh unknown
- 2003-06-20 AR ARP030102198A patent/AR039714A1/es unknown
-
2004
- 2004-11-29 NO NO20045223A patent/NO20045223L/no not_active Application Discontinuation
- 2004-11-30 ZA ZA200409693A patent/ZA200409693B/en unknown
- 2004-12-09 IL IL16567004A patent/IL165670A0/xx unknown
-
2005
- 2005-01-05 IS IS7626A patent/IS7626A/is unknown
- 2005-08-16 HK HK05107074A patent/HK1074779A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1517679B1 (en) | 2008-02-13 |
| PT1517679E (pt) | 2008-04-21 |
| DE60319082D1 (de) | 2008-03-27 |
| SE0201936D0 (sv) | 2002-06-20 |
| EP1517679A1 (en) | 2005-03-30 |
| CN1307988C (zh) | 2007-04-04 |
| NO20045223L (no) | 2005-03-17 |
| NZ536971A (en) | 2006-05-26 |
| CA2490684A1 (en) | 2003-12-31 |
| AU2003240100A1 (en) | 2004-01-06 |
| RU2004135543A (ru) | 2005-08-10 |
| RU2288912C2 (ru) | 2006-12-10 |
| BR0311839A (pt) | 2005-04-05 |
| CN1674883A (zh) | 2005-09-28 |
| ATE385790T1 (de) | 2008-03-15 |
| DE60319082T2 (de) | 2009-01-29 |
| MXPA04012685A (es) | 2005-03-23 |
| WO2004000294A1 (en) | 2003-12-31 |
| JP2005535618A (ja) | 2005-11-24 |
| IL165670A0 (en) | 2006-01-15 |
| ES2299703T3 (es) | 2008-06-01 |
| HK1074779A1 (en) | 2005-11-25 |
| AR039714A1 (es) | 2005-03-09 |
| ZA200409693B (en) | 2005-10-11 |
| KR20050014015A (ko) | 2005-02-05 |
| PL375080A1 (en) | 2005-11-14 |
| AU2003240100B2 (en) | 2006-06-01 |
| UA76627C2 (en) | 2006-08-15 |
| IS7626A (is) | 2005-01-05 |
| TW200407114A (en) | 2004-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013029I1 (el) | Νεα παραγωγα ινσουλινης | |
| DK1660431T3 (da) | Phenoxyeddikesyrederivater | |
| DK1542748T3 (da) | Engangssprøjte | |
| DK1471057T3 (da) | Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2 | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| DK2275439T3 (da) | Hidtil ukendte insulinderivater | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| HK1073838A1 (en) | Ortho-substituted benzoic acid derivatives for thetreatment of insulin resistance | |
| DK1434588T3 (da) | 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte | |
| DE602004022010D1 (de) | Sicherheitsspritze | |
| DK1517679T3 (da) | Ortosubstituerede benzoesyrederivater til behandling af insulinresistens | |
| DE60324703D1 (de) | Barbitursäure derivaten. | |
| FI20021783A0 (sv) | Förfarande för att upptäcka risken för kardiovaskulära sjukdomar | |
| DK1497290T3 (da) | Fremgangsmåde til fremstilling af syresalte af gemifloxacin | |
| DK1620085T3 (da) | Anvendelse af phenoxyacetatsyrederivater til behandling af hyperaktiv blære | |
| DK1593391T3 (da) | Lægemiddel til degenererede båndskiver | |
| SI1517883T1 (sl) | Orto-substituirani derivati benzojske kisline za zdravljenje insulinske rezistence | |
| SI1517679T1 (sl) | Orto-substituirani derivati benzojske kisline za zdravljenje insulinske rezistence | |
| ES1051002Y (es) | Jeringa perfeccionada. | |
| ES1055675Y (es) | Jeringa perfeccionada. | |
| IS8301A (is) | Nýjar fúsíðsýruafleiður | |
| UA6623S (uk) | Шприц | |
| ITVI20020014A1 (it) | Siringa monouso | |
| UA6774S (uk) | Натільна пов`язка для суглобів | |
| ES1050579Y (es) | Jeringuilla perfeccionada |